Not Signed In - New Study Reports Increased Response To Therapy With No Added Toxicity In Treatment Of Recurrent Ovarian Cancer
Sun, 26 Mar 2006 11:00 PM EST
... In a study released todayat the Society of Gynecologic Oncologists 37th Annual Meeting on Women''sCancer, researchers found the addition of thalidomide to topotecan for thetreatment of recurrent ovarian cancer significantly increases the response totherapy and the duration of progression free survival without additionaltoxicity... click link for more info. ...
Related Topics
- Ovarian Cancer
- Ovarian Cysts
- Cancers
- Prostate Cancer
- Uterine Cancer
- Cancer Radiation Therapy
- Cancer Alternative Therapy
- Small Cell Lung Cancer
- Disaster Response
- Radiation Therapy
- Thyroid Cancer
- Metastatic Cancer
- Chelation therapy
- Liver Cancer
- Natural therapy
- Natural therapies
- Radiation
- Cancer
- Chemotherapy
- Treatment
email this page
print this page
bookmark this page
feedback on this page
